143 related articles for article (PubMed ID: 6657511)
1. Neuropeptides in spinal cord injury: comparative experimental models.
Faden AI; Jacobs TP; Smith GP; Green B; Zivin JA
Peptides; 1983; 4(5):631-4. PubMed ID: 6657511
[TBL] [Abstract][Full Text] [Related]
2. Endogenous opioids in spinal cord injury: a critical evaluation.
Long JB; Martinez-Arizala A; Petras JM; Holaday JW
Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
[TBL] [Abstract][Full Text] [Related]
3. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.
Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
Ann Neurol; 1985 Apr; 17(4):386-90. PubMed ID: 2860844
[TBL] [Abstract][Full Text] [Related]
4. Endorphins in experimental spinal injury: therapeutic effect of naloxone.
Faden AI; Jacobs TP; Mougey E; Holaday JW
Ann Neurol; 1981 Oct; 10(4):326-32. PubMed ID: 6274252
[TBL] [Abstract][Full Text] [Related]
5. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
[TBL] [Abstract][Full Text] [Related]
6. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
Faden AI; Jacobs TP
Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
[TBL] [Abstract][Full Text] [Related]
7. A role for endorphins in the pathophysiology of spinal cord injury.
Faden AI; Holaday JW
Adv Biochem Psychopharmacol; 1981; 28():435-46. PubMed ID: 7211553
[TBL] [Abstract][Full Text] [Related]
8. Contrasting actions of naloxone in experimental spinal cord trauma and cerebral ischemia: a review.
Hamilton AJ; Black PM; Carr DB
Neurosurgery; 1985 Nov; 17(5):845-9. PubMed ID: 2999639
[TBL] [Abstract][Full Text] [Related]
9. Motor dysfunction after spinal cord injury is mediated by opiate receptors.
Faden AI; Knoblach S; Mays C; Jacobs TP
Peptides; 1985; 6 Suppl 1():15-7. PubMed ID: 2995941
[TBL] [Abstract][Full Text] [Related]
10. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
Faden AI
Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
[TBL] [Abstract][Full Text] [Related]
11. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
Faden AI
Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
[TBL] [Abstract][Full Text] [Related]
12. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
Faden AI; Sacksen I; Noble LJ
J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
[TBL] [Abstract][Full Text] [Related]
13. Opiate antagonist in traumatic shock.
McIntosh TK; Faden AI
Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
[TBL] [Abstract][Full Text] [Related]
14. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
[TBL] [Abstract][Full Text] [Related]
16. Blocking weight-induced spinal cord injury in rats: effects of TRH or naloxone on motor function recovery and spinal cord blood flow.
Holtz A; Nyström B; Gerdin B
Acta Neurol Scand; 1989 Sep; 80(3):215-20. PubMed ID: 2508415
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
Bakshi R; Newman AH; Faden AI
J Neurosci; 1990 Dec; 10(12):3793-800. PubMed ID: 1980130
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides and central nervous system injury. Clinical implications.
Faden AI
Arch Neurol; 1986 May; 43(5):501-4. PubMed ID: 2870700
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin induces partially reversible paraplegia in the rat.
Faden AI; Jacobs TP
Eur J Pharmacol; 1983 Jul; 91(2-3):321-4. PubMed ID: 6137396
[TBL] [Abstract][Full Text] [Related]
20. TRH fails to antagonize the acute paralytic effects of intrathecal dynorphin A and substance P antagonists in the rat.
Martinez-Arizala A; Long JB; Holaday JW
Brain Res; 1988 Nov; 473(2):385-8. PubMed ID: 2466528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
